Telix Pharmaceuticals | TLX - Trade Creditors



Telix Pharmaceuticals reported AUD68.7M in Trade Creditors for its fiscal semester ending in December of 2024.


Trade Creditors Change Date
Cochlear AUD 285.5M 17.7M Dec/2024
CSL USD 2.98B 2.11B Dec/2024
Integral Diagnostics 28.28M 17.87M Dec/2023
Mayne Pharma AUD 20.87M 21.9M Jun/2024
Medical Developments International AUD 5.15M 3.11M Dec/2024
Mesoblast 7.07M 3.69M Jun/2024
Neuren Pharmaceuticals 1.45M 3.03M Dec/2024
Pacific Edge 2.64M 489K Mar/2025
Paradigm Biopharmaceuticals AUD 580.84K 2.24M Dec/2024
Polynovo AUD 6.39M 2.84M Jun/2024
PYC Therapeutics AUD 7.53M 116.62K Jun/2024
Ramsay Health Care 1.65B 1.31B Jun/2024
ResMed USD 278.16M 57.85M Jun/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024